SCHEMBL29640756

SCHEMBL29640756

CCC(C)(C#N)n1cc(Br)cn1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18603248 0.79 F2 (0.37) ALDH1A1
SCHEMBL21819552 0.77 ALDH1A1 (0.35) ALDH1A1
SCHEMBL20202071 0.76
SCHEMBL673370 0.72 ALDH1A1 (0.35) ALDH1A1
SCHEMBL9274705 0.69 KIT (0.33) ALDH1A1
SCHEMBL1582031 0.68 KIT (0.43) ALDH1A1
SCHEMBL23210491 0.66 PDK2 (0.34) ALDH1A1
SCHEMBL21819400 0.66 ALDH1A1 (0.32) ALDH1A1
SCHEMBL21794979 0.66 ELANE (0.34) ALDH1A1
SCHEMBL2766588 0.66 ALDH1A1 (0.35) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112218857-B P300/CBP HAT inhibitors and methods of use thereof 星座制药公司 2023-11-21 CN disclosed
EP-4003342-A1 COMPOUNDS FOR USE IN TREATING NEUROLOGICAL DISORDERS Constellation Pharmaceuticals, Inc. (US) 2022-06-01 EP disclosed
CN-114450005-A Compounds for the treatment of neurological disorders 星座制药公司 2022-05-06 CN disclosed